According to Santhera Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -C$76.7 M. In 2023 the company made an earning of C$0.12 B an increase over its 2022 earnings that were of -C$74.05 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.